We are live on ! Find out more
SGCM

Sand Grove Capital Management Portfolio holdings

AUM $444M
1-Year Est. Return 131.11%
This Fund
S&P 500
This Quarter Est. Return
+37.92%
1 Year Est. Return
+131.11%
3 Year Est. Return
+410.73%
5 Year Est. Return
+1,022.21%
10 Year Est. Return
+24,985.77%
AUM
$295M
AUM Growth
+$90.3M
Cap. Flow
+$54.8M
Cap. Flow %
18.58%
Top 10 Hldgs %
88.7%
Holding
21
New
9
Increased
3
Reduced
Closed
9

Top Buys

Rank Stock Value
1
HOLX
Hologic
HOLX
+$27.6M
2
WBD icon
Warner Bros
WBD
+$23.8M
3
RNAM
Avidity Biosciences
RNAM
+$21.4M
4
KVUE icon
Kenvue
KVUE
+$20.8M
5
EXAS
Exact Sciences
EXAS
+$18.4M

Top Sells

Rank Stock Value
1
K
Kellanova
K
+$26.7M
2
MRUS
Merus
MRUS
+$22.5M
3
STAA icon
STAAR Surgical
STAA
+$22.3M
4
CYBR
CyberArk
CYBR
+$18.9M
5
OMC icon
Omnicom Group
OMC
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 47.5%
2 Communication Services 19.61%
3 Utilities 11.91%
4 Industrials 8.3%
5 Consumer Staples 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXNM
1
TXNM Energy Inc
TXNM
$6.39B
$35.1M 11.91%
596,592
+3,481
+0.6% +$201K
WBD icon
2
Warner Bros
WBD
$64.3B
$29.3M 9.94%
+1,017,144
New +$23.8M
EA icon
3
Electronic Arts
EA
$52.4B
$28.5M 9.67%
139,595
+28,320
+25% +$5.72M
HOLX
4
DELISTED
Hologic
HOLX
$28.2M 9.54%
+377,962
New +$27.6M
NSC icon
5
Norfolk Southern
NSC
$75.4B
$24.5M 8.3%
84,786
+394
+0.5% +$114K
RNAM
6
DELISTED
Avidity Biosciences
RNAM
$23.9M 8.11%
+331,605
New +$21.4M
DVAX
7
DELISTED
Dynavax Technologies
DVAX
$23.5M 7.97%
+1,528,853
New +$16.8M
FOLD
8
DELISTED
Amicus Therapeutics
FOLD
$23.5M 7.95%
+1,647,030
New +$16.2M
EXAS
9
DELISTED
Exact Sciences
EXAS
$23.2M 7.88%
+228,799
New +$18.4M
KVUE icon
10
Kenvue
KVUE
$38B
$21.9M 7.43%
+1,270,766
New +$20.8M
CDTX
11
DELISTED
Cidara Therapeutics
CDTX
$17.9M 6.05%
+80,821
New +$13.1M
AXTA icon
12
Axalta
AXTA
$7.45B
$15.5M 5.25%
+479,281
New +$14.1M
ALE
13
DELISTED
Allete
ALE
-168,499
Closed -$11.2M
CCRN
14
DELISTED
Cross Country Healthcare
CCRN
-191,904
Closed -$2.73M
CYBR
15
DELISTED
CyberArk
CYBR
-39,121
Closed -$18.9M
K
16
DELISTED
Kellanova
K
-325,866
Closed -$26.7M
MRUS
17
DELISTED
Merus
MRUS
-239,378
Closed -$22.5M
OMC icon
18
Omnicom Group
OMC
$23.5B
-185,285
Closed -$15.1M
RKT icon
19
Rocket Companies
RKT
$38.8B
-6
Closed -$116
SRDX
20
DELISTED
Surmodics
SRDX
-129,557
Closed -$3.87M
STAA icon
21
STAAR Surgical
STAA
$1.19B
-829,123
Closed -$22.3M

Similar funds

Sand Grove Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Sand Grove Capital Management held 21 positions worth $295M, up 44% from $205M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Sand Grove Capital Management deployed $54.8M of net new capital in Q4 2025, opening 9 new positions and adding to 3 existing holdings. Its largest new stake was Hologic: 377,962 shares worth $28.2M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 25% a quarter earlier, followed by Communication Services and Utilities.

On the sell side, the most notable exit was Kellanova, an estimated $26.7M sold.

  • Sand Grove Capital Management's largest Q4 2025 buy was Hologic: 377,962 shares worth $28.2M.
  • Sand Grove Capital Management added most to Electronic Arts in Q4 2025, an estimated $5.72M increase.
  • Sand Grove Capital Management fully exited Kellanova in Q4 2025, selling an estimated $26.7M.
  • Sand Grove Capital Management's ten largest holdings make up 89% of its $295M portfolio in Q4 2025.
  • Sand Grove Capital Management opened 9 new positions and closed 9 in Q4 2025.
  • Sand Grove Capital Management's portfolio value rose 44% quarter-over-quarter to $295M.

Based on Sand Grove Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.